Market overview
The global 1-step RT-PCR kits market is worth USD 728 mn in 2026 and is forecast to reach USD 1.2 bn by 2036, growing at a 5.0% CAGR. United States is the largest country market and Probe-based qPCR is the largest by detection segment.
| Scope | Ready-to-use kits that combine reverse transcription and PCR amplification in one tube, for RNA virus detection, gene expression and clinical molecular testing. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 700 mn |
| Value 2026 | USD 728 mn |
| Value 2036 | USD 1.2 bn |
| CAGR 2026-2036 | 5.0% |
| Volume 2026 | 499 million reactions |
| Volume 2036 | 813 million reactions |
| Average price 2026 | USD 1.46 per reaction |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
1-Step RT-PCR Kits market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 728.0 mn |
| 2027 | USD 764.4 mn |
| 2028 | USD 802.6 mn |
| 2029 | USD 842.8 mn |
| 2030 | USD 884.9 mn |
| 2031 | USD 929.1 mn |
| 2032 | USD 975.6 mn |
| 2033 | USD 1.02 bn |
| 2034 | USD 1.08 bn |
| 2035 | USD 1.13 bn |
| 2036 | USD 1.19 bn |
1-Step RT-PCR Kits market segmentation
By detection
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Probe-based qPCR | 58.0% | 57.8% | USD 422 mn | 5.0% |
| Dye-based qPCR | 20.0% | 18.1% | USD 146 mn | 4.0% |
| End-point and digital | 22.0% | 24.1% | USD 160 mn | 6.0% |
By end use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Clinical diagnostics | 42.0% | 42.4% | USD 306 mn | 5.1% |
| Academic and research | 30.0% | 27.5% | USD 218 mn | 4.1% |
| Biopharma and CROs | 18.0% | 20.0% | USD 131 mn | 6.1% |
| Public health and food testing | 10.0% | 10.1% | USD 73 mn | 5.1% |
By target
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Respiratory viruses | 34.0% | 30.0% | USD 248 mn | 3.7% |
| Hepatitis and HIV | 16.0% | 16.0% | USD 116 mn | 5.0% |
| Gene expression research | 30.0% | 32.0% | USD 218 mn | 5.7% |
| Other infections and oncology RNA | 20.0% | 22.0% | USD 146 mn | 6.0% |
By kit format
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Liquid master mix | 46.0% | 44.0% | USD 335 mn | 4.5% |
| Freeze-dried | 22.0% | 23.0% | USD 160 mn | 5.5% |
| Multiplex panels | 32.0% | 33.0% | USD 233 mn | 5.3% |
By throughput
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Manual single tests | 34.0% | 31.0% | USD 248 mn | 4.0% |
| Mid-throughput | 38.0% | 38.0% | USD 277 mn | 5.0% |
| Automated high throughput | 28.0% | 31.0% | USD 204 mn | 6.1% |
Top 25 countries for 1-step RT-PCR kits by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 85.5% of 2026 revenue and the 25 countries below together hold 95.0%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 248 mn | 34.0% | USD 372 mn | 4.2% |
| 2 | China | USD 116 mn | 16.0% | USD 212 mn | 6.2% |
| 3 | Germany | USD 51 mn | 7.0% | USD 81 mn | 4.7% |
| 4 | Japan | USD 44 mn | 6.0% | USD 65 mn | 4.1% |
| 5 | United Kingdom | USD 36 mn | 5.0% | USD 57 mn | 4.6% |
| 6 | France | USD 29 mn | 4.0% | USD 46 mn | 4.7% |
| 7 | South Korea | USD 29 mn | 4.0% | USD 53 mn | 6.2% |
| 8 | India | USD 25 mn | 3.5% | USD 56 mn | 8.1% |
| 9 | Canada | USD 22 mn | 3.0% | USD 34 mn | 4.6% |
| 10 | Italy | USD 22 mn | 3.0% | USD 34 mn | 4.6% |
| 11 | Spain | USD 7.7 mn | 1.1% | USD 12 mn | 4.4% |
| 12 | Australia | USD 6.4 mn | 0.9% | USD 10.0 mn | 4.5% |
| 13 | Netherlands | USD 5.8 mn | 0.8% | USD 8.9 mn | 4.5% |
| 14 | Brazil | USD 5.8 mn | 0.8% | USD 10.0 mn | 5.7% |
| 15 | Switzerland | USD 5.1 mn | 0.7% | USD 8.0 mn | 4.5% |
| 16 | Taiwan | USD 5.1 mn | 0.7% | USD 8.0 mn | 4.5% |
| 17 | Singapore | USD 4.5 mn | 0.6% | USD 7.8 mn | 5.7% |
| 18 | Sweden | USD 3.9 mn | 0.5% | USD 5.9 mn | 4.4% |
| 19 | Belgium | USD 3.9 mn | 0.5% | USD 5.9 mn | 4.4% |
| 20 | Israel | USD 3.9 mn | 0.5% | USD 6.6 mn | 5.6% |
| 21 | Saudi Arabia | USD 3.9 mn | 0.5% | USD 7.3 mn | 6.7% |
| 22 | Turkey | USD 3.9 mn | 0.5% | USD 6.6 mn | 5.6% |
| 23 | Poland | USD 3.2 mn | 0.4% | USD 5.6 mn | 5.7% |
| 24 | Mexico | USD 3.2 mn | 0.4% | USD 5.6 mn | 5.7% |
| 25 | Thailand | USD 3.2 mn | 0.4% | USD 6.2 mn | 6.8% |
| Rest of world | USD 36 mn | 5.0% | USD 60 mn | 5.2% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Qiagen
- Roche
- Agilent Technologies
- Merck KGaA
Group 2: Regional and specialist players
- New England Biolabs
- Promega
- Takara Bio
- Revvity
- Integrated DNA Technologies
- Seegene
- Sansure Biotech
- Daan Gene
- Toyobo
Group 3: Emerging and niche players
- Meridian Bioscience
- Vazyme
- Biotium
- Norgen Biotek
- Novacyt
- Bioneer
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the 1-step RT-PCR kits market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.0% is calculated from the resulting values.
The market is divided by detection, by end use, by target, by kit format, by throughput. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the 1-step RT-PCR kits market?
The global 1-step RT-PCR kits market is estimated at USD 700 mn in 2025 and USD 728 mn in 2026.
How fast will the 1-step RT-PCR kits market grow?
It is forecast to reach USD 1.2 bn by 2036, a compound annual growth rate of 5.0% from 2026, an increase of USD 458 mn.
Which country is the largest market for 1-step RT-PCR kits?
United States is the largest market by revenue at USD 248 mn in 2026, 34.0% of the global total. The three largest countries together hold 57.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 8.1% a year from 2026 to 2036.
Which 1-step RT-PCR kits segment is largest?
In the by detection split, Probe-based qPCR is the largest segment with 58.0% of 2026 revenue.
Who are the leading 1-step RT-PCR kits companies?
Global leaders include Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Roche.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Patient-Specific Surgical Implant DesignUSD 722 mn · 10.5% CAGR
- Nasal Congestion Treatment DevicesUSD 735 mn · 4.8% CAGR
- Extracorporeal Membrane OxygenationUSD 738 mn · 5.5% CAGR
- Fluid Bed DryerUSD 742 mn · 6.0% CAGR
- Smart InhalerUSD 713 mn · 15.0% CAGR
- Cervical Spacer SystemsUSD 746 mn · 6.0% CAGR
- Assistive Robots for DisabilityUSD 694 mn · 11.0% CAGR
- AI-Powered Behavioral TherapyUSD 768 mn · 17.0% CAGR